MK
Maiken Keson-Brookes
Chief Legal Officer

Maiken Keson-Brookes insider trades: Mural Oncology (MURA) stock sales

Chief Legal Officer, Mural Oncology Last trade Jul 22, 2025 13 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2021
3
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Maiken reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 22, 2025MURA↓ Sell$6K
Jul 18, 2025MURA↓ Sell$5K
Mar 5, 2025MURA↓ Sell$9K
Dec 23, 2024MURA↓ Sell$8K
Jul 18, 2024MURA↓ Sell$7K
Feb 1, 2022RUBY↓ Sell$18K
Mar 15, 2021RUBY↓ Sell$506K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MURA insiders

Open-market trades in the last 12 months

About Maiken Keson-Brookes's insider trades

Maiken Keson-Brookes is Chief Legal Officer at Mural Oncology (MURA). Since Mar 15, 2021, Maiken has reported no open-market purchases and 7 sales worth $561K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (7 filings), option exercises (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MURA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.